ClinicalTrials.Veeva

Menu

Technology-Supported Treatment of Sleep Apnea in Prediabetes (TECH)

The University of Chicago logo

The University of Chicago

Status

Enrolling

Conditions

Overweight or Obesity
Sleep Apnea
PreDiabetes

Treatments

Behavioral: Diet and exercise coaching
Other: CPAP Treatment

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04225507
IRB19-1445
R01DK120312 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Despite the efficacy of intensive lifestyle interventions in prediabetes, the incidence of diabetes is rising, and thus there is a critical need for additional strategies to prevent diabetes and to reduce its cardiovascular complications in this high-risk population. Sleep apnea is a highly common condition in prediabetes, but it has been mostly ignored and undertreated in current practice. The proposed study will be the first to assess whether adding CPAP (continuous positive air pressure) treatment to a lifestyle intervention improves cardiometabolic outcomes beyond that achieved with lifestyle alone (i.e. current standard of care) in high-risk individuals with prediabetes.

Full description

This is a 6-month randomized controlled, parallel group trial with two arms. After baseline, the subjects will be randomized to lifestyle intervention alone (lifestyle group) or lifestyle plus CPAP intervention (lifestyle plus CPAP group). The same metabolic and cardiovascular assessments will be performed at baseline and after 6-months of intervention.

The lifestyle group will aim to achieve a weight loss through diet and exercise. The lifestyle plus CPAP group will additionally receive CPAP treatment. All subjects will use a custom smartphone app to track weight loss and/or CPAP goals and will receive weekly coaching phone calls to maximize treatment adherence.

Enrollment

174 estimated patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Overweight or obese
  • Prediabetes
  • Sleep apnea

Exclusion criteria

  • Diabetic
  • enrolled in a formal weight loss program
  • Any underlying disease likely to limit life span and/or increase risk of interventions

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

174 participants in 2 patient groups

Lifestyle Intervention
Other group
Description:
Diet and exercise.
Treatment:
Behavioral: Diet and exercise coaching
Lifestyle Plus CPAP Intervention
Experimental group
Description:
CPAP treatment, diet and exercise.
Treatment:
Other: CPAP Treatment
Behavioral: Diet and exercise coaching

Trial contacts and locations

1

Loading...

Central trial contact

Olivia Hughes; Esra Tasali, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems